Home > Balance Sheet > CONCORD BIOTECH

CONCORD BIOTECH
Total Non-Current Liabilities

    Back to Balance Sheet
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹48 Cr₹37 Cr₹32 Cr₹32 Cr₹54 Cr

What is the latest Total Non-Current Liabilities ratio of CONCORD BIOTECH ?

The latest Total Non-Current Liabilities ratio of CONCORD BIOTECH is ₹48 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹48 Cr
Mar2025₹37 Cr
Mar2024₹32 Cr
Mar2023₹32 Cr
Mar2022₹54 Cr

How is Total Non-Current Liabilities of CONCORD BIOTECH Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹48 Cr
26.96
Mar2025 ₹37 Cr
17.43
Mar2024 ₹32 Cr
-0.71
Mar2023 ₹32 Cr
-40.93
Mar2022 ₹54 Cr -

Compare Total Non-Current Liabilities of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹14,146.1 Cr 6.4% 0.5% -25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,644.0 Cr 1.1% 7.2% 15.4% Stock Analytics
DIVIS LABORATORIES ₹184,053.0 Cr 2.4% 4.2% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹167,464.0 Cr 1.9% 8.3% 45.6% Stock Analytics
CIPLA ₹115,263.0 Cr -1.8% 3.2% -4.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,049.0 Cr -8.8% -3.2% -4.6% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

6.4%

0.5%

-25%

SENSEX

-0.9%

4.9%

-6.8%


You may also like the below Video Courses